US Stock MarketDetailed Quotes
BIVI BioVie
- 0.485
- -0.004-0.84%
Close Apr 26 16:00 ET
- 0.502
- +0.018+3.61%
Pre 08:57 ET
26.63MMarket Cap-414P/E (TTM)
0.502High0.479Low317.00KVolume0.481Open0.489Pre Close154.66KTurnover1.02%Turnover RatioLossP/E (Static)54.92MShares8.69052wk High3.56P/B15.04MFloat Cap0.44552wk Low--Dividend TTM31.03MShs Float46.098Historical High--Div YieldTTM4.66%Amplitude0.445Historical Low0.487Avg Price1Lot Size
About BioVie Company
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
Company Profile
SymbolBIVI
Company NameBioVie
Listing DateSep 18, 2020
Issue Price10.00
Founded2013
CEOMr. Cuong Viet Do
MarketNASDAQ
Employees13
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
Address680 West Nye Lane,Suite 201
CityCarson City
ProvinceNevada
CountryUnited States of America
Zip Code89703
Phone1-775-888-3162
Websitehttp://www.bioviepharma.com
Company Executives
- Name
- Position
- Salary
- Cuong Viet Do
- Director, President and Chief Executive Officer
- 2.34M
- Dr. Joseph M. Palumbo, M.D.
- Chief Medical Officer
- 1.09M
- Joanne Wendy Kim
- Chief Financial Officer, Treasurer and Corporate Secretary
- 723.87K
- James Lang
- Chairman of the Board
- 266.70K
- Richard J. Berman
- Independent Director
- 266.70K
- Michael Sherman, J.D.
- Independent Director
- 304.50K
- Dr. Robert J. Hariri, M.D.,PhD
- Independent Director
- 209.55K
- Steve Gorlin
- Independent Director
- 209.55K
- Sigmund Rogich
- Independent Director
- 223.30K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg